Population Pharmacokinetics of Lopinavir and Ritonavir in Combination With Rifampicin-Based Antitubercular Treatment in HIV-infected Children

Antiviral Therapy - United Kingdom
doi 10.3851/imp1915
Full Text
Abstract

Available in full text

Date
Authors
Publisher

International Medical Press

Related search

Lopinavir/Ritonavir Population Pharmacokinetics in Neonates and Infants

British Journal of Clinical Pharmacology
Pharmacology
2011English

Long-Term Safety and Effectiveness of Lopinavir/Ritonavir in Antiretroviral-Experienced HIV-1-infected Children

Archives of Disease in Childhood
Child HealthPediatricsPerinatology
2010English

The Efficacy of Nelfinavir and Lopinavir/Ritonavir in the Treatment of HIV-infected Pediatric Patients

Medical Herald of the South of Russia
2018English

Lopinavir/Ritonavir Treatment Increases the Placental Transfer of Bupivacaine Enantiomers in HIV-infected Pregnant Women

British Journal of Clinical Pharmacology
Pharmacology
2018English

Pharmacokinetics of Darunavir/Ritonavir in Asian HIV-1 Infected Children Aged >=7 Years

Antiviral Therapy
Infectious DiseasesPharmacology
2012English

Covariate Effects and Population Pharmacokinetics of Lamivudine in HIV-infected Children

British Journal of Clinical Pharmacology
Pharmacology
2014English

Lopinavir/Ritonavir in the Treatment of HIV-1 Infection: A Review

Therapeutics and Clinical Risk Management
2008English

Costs of Care of HIV-Infected Children Initiating Lopinavir/Ritonavir-Based Antiretroviral Therapy Before the Age of Two in Cote D’Ivoire

PLoS ONE
Multidisciplinary
2016English

Cost-Effectiveness of Atazanavir/Ritonavir Against Lopinavir/Ritonavir in the Treatment of People Living With Hiv in Peru

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy